Oppenheimer (as of 3/31/2016) added 32K shares. Now holding 102K. An increase of 45.07%.
Must be believing in PSTI.
So, as the saying goes - "it's a long way to Tiperray".
I can only hope that Pluristem will come out with a product in my lifetime. Otherwise, I will leave my shares as inheritance to my children.
Bite the bullet?
With 25% probability of success, we see BrainStorm worth $250 million, or $10 per share and we continue to rate the stock a ‘Buy’.
Pluristem mentioned, among other biomed companies.
Thanks, but it is already irrelevant. The edited transcript has already been published.
But comments are welcomed.
With all the junk posted here, it is very difficult to read the important msgs.
Note the word "likely", in the following paragraph:
An Israeli bio-tech company has developed an anti-radiation therapy that the US government will likely begin stocking next year, and which is able to cure 100% of patients exposed to unconventional radiological incidents like a terrorist dirty bomb, or an attack on a nuclear power plant.
There's no contract yet and it probably all depends on the results of injecting large animals.
True, it is very promising, but let's not jump to false conclusions.